Affimed

(OTC) AFMDQ

Current Price$0.00

Market Cap$4,600

Since IPO (2014)-100%

5 Year-100%

1 Year-100%

1 Month+0%

Affimed Financials at a Glance

Market Cap

$4,600

Revenue (TTM)

$877.00K

Net Income (TTM)

$69.97M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1324.33 (High)

Dividend

$0.00

Beta (Volatility)

1324.33 (High)

Price

$0.00

Volume

3,524

Open

$0.00

Price

$0.00

Volume

3,524

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.73

Dividend

$0.00

Beta (Volatility)

1324.33 (High)

Price

$0.00

Volume

3,524

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.73

AFMDQ News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Affimed

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Shawn M. Leland, PharmD

Website

www.affimed.com

Headquarters

Mannheim, 68165, DE

AFMDQ Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-13%

Net Income Margin

-13%

Return on Equity

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.60K

Shares Outstanding

15.23M

Volume

3.52K

Avg. Volume

4.79K

Financials (TTM)

Gross Profit

$8.28M

Operating Income

$106.66M

EBITDA

$102.38M

Operating Cash Flow

$110.27M

Capital Expenditure

$3.73M

Free Cash Flow

$114.00M

Cash & ST Invst.

$72.90M

Total Debt

$19.35M

Affimed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$155.00K

-92.1%

Gross Profit

$155.00K

-92.1%

Gross Margin

100.00%

N/A

Market Cap

$4.60K

N/A

Market Cap/Employee

$60.53

N/A

Employees

N/A

Net Income

$15.14M

+37.8%

EBITDA

$14.45M

+37.7%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Net Cash

$12.05M

-84.2%

Accounts Receivable

$4.54M

+85.7%

Inventory

$0.00

-100.0%

Long Term Debt

$5.99M

-58.8%

Short Term Debt

$6.90M

+5.6%

Return on Assets

-1.09%

N/A

Return on Invested Capital

-1.50%

N/A

Free Cash Flow

$11.14M

+48.1%

Operating Cash Flow

$11.13M

+39.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ONCROncorus, Inc.

ONCROncorus, Inc.$0.13-3.08%

IDRAIdera Pharmaceuticals, Inc.

IDRAIdera Pharmaceuticals, Inc.$0.42-23.04%

PHASPhaseBio Pharmaceuticals, Inc.

PHASPhaseBio Pharmaceuticals, Inc.$0.07+0.00%

ARAVAravive, Inc.

ARAVAravive, Inc.$0.04-13.39%

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$5.37+0.07%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

NOKNokia

NOKNokia$12.82+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.01+0.26%

Questions About AFMDQ

What is the current price of Affimed?

Affimed is trading at $0.00 per share.

What is the 52-week range for Affimed?

Over the past 52 weeks, Affimed has traded between $0.00 and $0.73.

How much debt does Affimed have?

As of the most recent reporting period, Affimed reported total debt of $14.38M.

How much cash does Affimed have on hand?

Affimed reported $8.26M in cash and cash equivalents in its most recent financial results.

What is Affimed’s dividend yield?

Affimed does not currently have a dividend yield.

Affimed

Affimed Financials at a Glance

AFMDQ News

Why Shares of Affimed Fell Thursday

Why Affimed Stock Plummeted by Over 16% Today

Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

Why Affimed Stock Is Heating Up Today

3 Under-the-Radar Biotech Stocks That Will Zoom Higher

3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale

Why Affimed Stock Is On Fire Today

Why Affirmed Stock Was Up More Than 12% Wednesday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Affimed

AFMDQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Affimed Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AFMDQ

What is the current price of Affimed?

What is the 52-week range for Affimed?

How much debt does Affimed have?

How much cash does Affimed have on hand?

What is Affimed’s dividend yield?

Premium Investing Services